Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.

MLA

Chase, Nicole M., et al. “Effectiveness of Omalizumab across Different Dosing Regimens in Patients with Moderate-to-Severe Allergic Asthma.” Respiratory Medicine, vol. 223, Mar. 2024, p. 107537. EBSCOhost, https://doi.org/10.1016/j.rmed.2024.107537.

APA

Chase, N. M., Littlejohn, M., Holweg, C. T. J., Millette, L. A., Seetasith, A., Steinke, J. W., Trzaskoma, B. L., Hanania, N. A., & Casale, T. B. (2024). Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respiratory Medicine, 223, 107537. https://doi.org/10.1016/j.rmed.2024.107537

Chicago

Chase, Nicole M, Monica Littlejohn, Cecile T J Holweg, Lauren A Millette, Arpamas Seetasith, John W Steinke, Benjamin L Trzaskoma, Nicola A Hanania, and Thomas B Casale. 2024. “Effectiveness of Omalizumab across Different Dosing Regimens in Patients with Moderate-to-Severe Allergic Asthma.” Respiratory Medicine 223 (March): 107537. doi:10.1016/j.rmed.2024.107537.